JD Health International Inc is a China-based investment holding company principally engaged in the Internet + Healthcare ecosystem business. The Company mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The Company mainly conducts its businesses in domestic market.

Employees

3,177

Sector

Drug Retailers

Calendar

31/03/2025 - Q4 2024 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
14/25/14	28.40 $	+3.09%	5,295,461
13/25/13	27.55 $	+2.23%	4,897,288
10/25/10	26.95 $	-5.11%	4,778,295
09/25/09	28.40 $	+1.61%	5,251,700
08/25/08	27.95 $	+0.72%	6,999,893

Delayed Quote Hong Kong S.E., January 14, 2025 at 01:38 pm IST

More quotes

Income Statement and Estimates

income-statement-evolution-chart JD-HEALTH-INTERNATIONAL-I

More financial data

Ratings

Trading Rating

Investor Rating

ESG MSCI

BBB

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

26.74CNY

Average target price

32.67CNY

Spread / Average Target

+22.17%

Consensus

Profit revisions

estimates-change-chart JD-HEALTH-INTERNATIONAL-I

Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart JD-HEALTH-INTERNATIONAL-I

Company calendar

Market Closed - Hong Kong S.E. Other stock markets 01:38:06 14/01/2025 pm IST			5-day change	1st Jan Change
28.40 ^HKD	+3.09%		+4.03%	+1.07%

18/11	Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	MT
14/11	JD Health International Records 212% Higher Profit, 15% Higher Revenue for Q3	MT

Capitalization	8.55TCr 9.08TCr 1.17TCr 1.13TCr 1.07TCr 956.77Cr 1.68TCr 1,01000Cr 1.88TCr 13TCr 4.84TCr 41TCr 4.38TCr 4.29TCr 1,84400Cr	P/E ratio 2024 *	26.8x	P/E ratio 2025 *	23.4x
Enterprise value	6.64TCr 7.05TCr 905.83Cr 879.93Cr 828.16Cr 742.82Cr 1.3TCr 78TCr 1.46TCr 10TCr 3.76TCr 32TCr 3.4TCr 3.33TCr 1,43200Cr	EV / Sales 2024 *	1.15x	EV / Sales 2025 *	0.95x
Free-Float	32.24%	Yield 2024 *	-	Yield 2025 *	-

Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	18/11	MT
JD Health International Records 212% Higher Profit, 15% Higher Revenue for Q3	14/11	MT
JD Health International Grants Share Awards Under Post-IPO Award Scheme	02/24/02	MT
Nomura Adjusts JD Health International's Price Target to HK$25 From HK$37, Keeps at Buy	19/24/19	MT
Hong Kong Stocks Extend Gains on US Rate Cut Hopes; Holly Futures Jumps 15%	19/24/19	MT
HK stocks drift higher on US rate outlook; China banks hit record peaks	19/24/19	RE
HK stocks drift higher on US rate outlook; China banks hit record peaks	19/24/19	RE
JD Health International Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	15/24/15	CI
JD Health's H1 Profit Surges to 2 Billion Yuan	15/24/15	MT
JD Health International Inc., H1 2024 Earnings Call, Aug 15, 2024	15/24/15
JD Health International Inc. Announces Appointment of Professor George Lau as Independent Non-Executive Director	15/24/15	CI
Morgan Stanley Downgrades JD Health International to Underweight From Equal-weight; Price Target is HK$20.40	17/24/17	MT
JD.com's Healthcare Arm Shuttering Family Doctor Initiative	29/24/29	MT

Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	18/11	MT
Nomura Adjusts JD Health International's Price Target to HK$25 From HK$37, Keeps at Buy	19/24/19	MT
Morgan Stanley Downgrades JD Health International to Underweight From Equal-weight; Price Target is HK$20.40	17/24/17	MT
Nomura Adjusts JD Health’s Price Target to HK$44 to HK$37, Keeps at Buy	22/24/22	MT
Nomura Adjusts JD Health International’s Price Target to HK$44 from HK$60, Keeps at Buy	19/24/19	MT

JD Health International Inc. Share Price

Equities

6618

KYG5074A1004

Drug Retailers

Valuation: JD Health International Inc.

Chart: JD Health International Inc.

Latest news: JD Health International Inc.

Last Transcript: JD Health International Inc.

Analysts' recommendations: JD Health International Inc.

Press Releases: JD Health International Inc.

News in other languages: JD Health International Inc.

Quotes and Performance

Course Extremes

Managers and Directors: JD Health International Inc.

ETFs: JD Health International Inc.

Other Drug Retailers

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly revenue - Rate of surprise

JD com misses estimates quarterly sales	15/24/15	AQ
JD.com verslaat verwachtingen	16/23/16	AQ
JD.com lacks estimates	09/23/09	AQ
JD Health International : Next Day Disclosure Return	01/22/01	PU
JD Health International : Next Day Disclosure Return	26/22/26	PU

Borse Cina : Hong Kong chiude a -0,85% con settore tech sotto pressione	03/24/03
Las acciones de Hong Kong terminan a la baja en un clima de aversión al riesgo -- Market Talk	02/23/02
Point marchés-Peu de changements en vue en Europe en attendant la Fed (actualisé)	04/22/04
Les valeurs à suivre mardi 7 septembre à Wall Street -	07/21/07
JD.com : le fondateur prend du recul	07/21/07

1 day	+3.09%
1 week	+4.03%
Current month	+1.07%
1 month	-4.54%
3 months	-1.22%
6 months	+24.84%
Current year	+1.07%

Director	Title	Age	Since
En Lin Jin CEO	Chief Executive Officer	45	06/09/2021
Deng Hui DFI	Director of Finance/CFO	39	11/05/2023
Ming King Chiu SEC	Corporate Secretary	47	-

Manager	Title	Age	Since
Qiang Dong Liu CHM	Chairman	53	14/09/2020
Qing Qing Yi BRD	Director/Board Member	53	21/08/2020
Xing Yao Chen BRD	Director/Board Member	51	-

Name	Weight	AuM	1st Jan change	Investor Rating
KRANESHARES CSI CHINA INTERNET UCITS ETF - GBP	4.51%	20 M€	-0.30%	-
KRANESHARES CSI CHINA INTERNET UCITS ETF - EUR	4.51%	105 M€	-1.59%	-
LEVERAGE SHARES -3X SHORT CHINA TECH ETP SECURITIES - USD	4.41%	0 M€	0.00%	-
KRANESHARES CSI CHINA INTERNET UCITS ETF - USD	3.58%	258 M€	-2.90%

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
JD HEALTH INTERNATIONAL INC.	+3.09%	+4.03%	-11.94%	-56.04%	1.13TCr
WALGREENS BOOTS ALLIANCE, INC.	+2.90%	+25.01%	-47.14%	-77.74%	1.03TCr
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+2.77%	+4.70%	-8.99%	-50.74%	671.25Cr
MATSUKIYOCOCOKARA & CO.	-2.51%	-2.98%	-18.08%	+59.87%	572.22Cr
CLICKS GROUP LIMITED	-0.47%	-1.86%	+18.57%	+18.89%	460.6Cr
NAHDI MEDICAL COMPANY	+1.19%	+1.53%	-15.32%	-	408.62Cr
YIFENG PHARMACY CHAIN CO., LTD.	+0.91%	+0.74%	-26.19%	-23.26%	400.17Cr
WELCIA HOLDINGS CO., LTD.	+0.54%	+6.25%	-10.26%	-35.31%	281.12Cr
CORPORATIVO FRAGUA, S.A.B. DE C.V.	-2.43%	-7.52%	+13.01%	+77.41%	269.83Cr
REDCARE PHARMACY NV	+4.43%	-6.87%	-8.36%	+6.89%	234.26Cr
Average	+1.07%	+1.91%	-11.47%	-8.89%	545.82Cr
Weighted average by Cap.	+1.50%	+4.36%	-16.10%	-25.98%

	2024 *	2025 *
Net sales	5.77TCr 6.13TCr 787.08Cr 764.57Cr 719.59Cr 645.44Cr 1.13TCr 68TCr 1.27TCr 8.81TCr 3.26TCr 28TCr 2.95TCr 2.89TCr 1,24400Cr	6.47TCr 6.88TCr 883.04Cr 857.78Cr 807.32Cr 724.12Cr 1.27TCr 76TCr 1.43TCr 9.88TCr 3.66TCr 31TCr 3.31TCr 3.24TCr 1,39600Cr
Net income	314.95Cr 334.48Cr 43Cr 42Cr 39Cr 35Cr 62Cr 3.72TCr 69Cr 480.7Cr 178.18Cr 1.52TCr 161.25Cr 157.8Cr 6.79TCr	364.76Cr 387.38Cr 50Cr 48Cr 45Cr 41Cr 71Cr 4.31TCr 80Cr 556.72Cr 206.35Cr 1.77TCr 186.76Cr 182.76Cr 7.86TCr
Net Debt	-1.91TCr -2.03TCr -260.9Cr -253.44Cr -238.53Cr -213.95Cr -374.6Cr -23TCr -421.48Cr -2.92TCr -1.08TCr -9.26TCr -979.28Cr -958.33Cr -41TCr	-2.37TCr -2.52TCr -323.52Cr -314.26Cr -295.78Cr -265.3Cr -464.5Cr -28TCr -522.64Cr -3.62TCr -1.34TCr -11TCr -1.21TCr -1.19TCr -51TCr